This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Comperative Trial Between an Accommodative Iol and Monofocal Iol

This study has been withdrawn prior to enrollment.
(Company could not supply the accommodating intraocular lenses for the study)
Information provided by (Responsible Party):
Dr. Yaacov Rozenman, Shaare Zedek Medical Center Identifier:
First received: January 17, 2008
Last updated: June 10, 2012
Last verified: June 2012
a comparison of two intraocular lenses in regard of accommodative power.

Condition Intervention
CATARACT SURGERY Device: Acrysof Device: Acuity's AIOL

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Randomized Single Blind Comparative Study of the Acuity's C-Well Accommodating Intra Occular Lens (AIOL) Against Alcon's Acrysof

Further study details as provided by Dr. Yaacov Rozenman, Shaare Zedek Medical Center:

Primary Outcome Measures:
  • distance and near visual acuity [ Time Frame: 1 year ]

Secondary Outcome Measures:
  • centration pco [ Time Frame: 1 year ]

Enrollment: 0
Study Start Date: March 2008
Estimated Study Completion Date: December 2012
Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Acrysof
Routine monofocal IOL
Device: Acrysof
Monofocal IOL
Active Comparator: Acuity's AIOL
Accomodaing IOL
Device: Acuity's AIOL
Accommodating IOL

Detailed Description:
A new accommodating IOL (Acuity Ltd, Israel) will be compared with Alcon's Acrysof for 1 year for visual acuity and distance and near best corrected visual acuity.

Ages Eligible for Study:   30 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Age between 30 and 65
  • Required cataract operation in one or both eyes
  • BCVA potetial at least 20/30
  • Clear intraoccular media
  • Willing to participate in study as evidenced by signing a written Informed Consent

Exclusion Criteria:Main

  • Prior surgery at the selected eye
  • No light perception or poor potential for improvement
  • Phacodonesis and damaged zonules
  • Pupil size at least 6 mm.
  • History of uveitis
  • Macular disease decreasing vision below 20/30
  • Amblyopia
  • Axial length shorter than 21 mm and longer than 25 mm
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

Responsible Party: Dr. Yaacov Rozenman, Head of eye department, Shaare Zedek Medical Center Identifier: NCT00604305     History of Changes
Other Study ID Numbers: 6666476CTIL
Study First Received: January 17, 2008
Last Updated: June 10, 2012

Additional relevant MeSH terms:
Lens Diseases
Eye Diseases processed this record on August 18, 2017